Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues.
This overview covers a wide range of cannabis topics, initially examining issues in dispensaries and self-administration, plus regulatory requirements for production of cannabis-based medicines, particularly the Food and Drug Administration "Botanical Guidance." The remainder pertains to various cannabis controversies that certainly require closer examination if the scientific, consumer, and governmental stakeholders are ever to reach consensus on safety issues, specifically: whether botanical cannabis displays herbal synergy of its components, pharmacokinetics of cannabis and dose titration, whether cannabis medicines produce cyclo-oxygenase inhibition, cannabis-drug interactions, and cytochrome P450 issues, whether cannabis randomized clinical trials are properly blinded, combatting the placebo effect in those trials via new approaches, the drug abuse liability (DAL) of cannabis-based medicines and their regulatory scheduling, their effects on cognitive function and psychiatric sequelae, immunological effects, cannabis and driving safety, youth usage, issues related to cannabis smoking and vaporization, cannabis concentrates and vape-pens, and laboratory analysis for contamination with bacteria and heavy metals. Finally, the issue of pesticide usage on cannabis crops is addressed. New and disturbing data on pesticide residues in legal cannabis products in Washington State are presented with the observation of an 84.6% contamination rate including potentially neurotoxic and carcinogenic agents. With ongoing developments in legalization of cannabis in medical and recreational settings, numerous scientific, safety, and public health issues remain.
PHYTECS Los Angeles, CA, USA.
Ethan B
EB
Russo
cannabis; clinical trials; cognition; driving; drug abuse liability; pesticides; placebo; vaporization
Epilepsy Behav. 2015 Apr;45:49-52
25845492
Life Sci. 1995;56(23-24):2097-102
7776837
Br J Psychiatry. 2010 Oct;197(4):285-90
20884951
Childs Nerv Syst. 2011 Apr;27(4):671-9
21336992
Clin Pharmacol Drug Dev. 2013 Jul;2(3):285-94
27121791
Lancet. 2007 Mar 24;369(9566):1047-53
17382831
Mult Scler. 2010 Jun;16(6):707-14
20558502
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1829-34
17035389
Front Pharmacol. 2016 Apr 27;7:108
27199751
J Psychopharmacol. 2016 Feb;30(2):159-68
26739345
J Agric Food Chem. 2002 Dec 18;50(26):7622-6
12475280
Eur J Neurol. 2011 Sep;18(9):1122-31
21362108
Chem Res Toxicol. 2008 Feb;21(2):494-502
18062674
Harm Reduct J. 2007 Apr 16;4:11
17437626
Expert Rev Neurother. 2012 Apr;12(4 Suppl):9-14
22509986
Pain. 2015 Dec;156(12):2616-2626
26307858
Psychopharmacology (Berl). 2002 Jun;161(4):331-9
12073159
J Psychoactive Drugs. 1998 Apr-Jun;30(2):187-96
9692381
Chem Res Toxicol. 2009 Jun;22(6):1181-8
19449825
Neurol Res. 2010 Jun;32(5):451-9
20307378
Clin Exp Immunol. 2005 Jun;140(3):580-5
15932522
Planta Med. 1996 Oct;62(5):469-70
9005452
J Neurol. 2013 Jan;260(1):285-95
22878432
J Agric Food Chem. 2001 May;49(5):2422-6
11368614
Ann Allergy Asthma Immunol. 2004 Mar;92(3):294-303; quiz 303-5, 355
15049392
Phytochemistry. 2010 Dec;71(17-18):2058-73
21040939
J Pain Palliat Care Pharmacother. 2014 Sep;28(3):216-25
25118789
J Clin Psychiatry. 1995 Oct;56(10):485-6
7559378
Trends Pharmacol Sci. 2016 Jul;37(7):594-605
27179600
Trends Pharmacol Sci. 2005 Feb;26(2):82-7
15681025
N Engl J Med. 2004 Oct 21;351(17):1709-11
15470192
JAMA. 2015 Jun 23-30;313(24):2491-3
26103034
Am J Respir Crit Care Med. 1997 Jan;155(1):141-8
9001303
Nat Prod Rep. 1999 Apr;16(2):131-43
10331283
Lancet. 2006 Apr 1;367(9516):1055
16581402
Eur J Pharmacol. 1998 Jul 17;353(1):23-31
9721036
Br Med J. 1947 Jul 12;2(4514):43-7
20251793
Eur Neurol. 2014;71 Suppl 1:10-5
24457847
Pain. 2005 Jan;113(1-2):9-19
15621359
Pain. 2008 Sep 15;138(3):657-666
18691815
J Psychopharmacol. 2008 Sep;22(7):707-16
18515447
Drug Alcohol Depend. 2015 Nov 1;156:207-212
26409752
Behav Pharmacol. 2005 Sep;16(5-6):487-96
16148455
Neurology. 2005 Sep 27;65(6):812-9
16186518
Transl Psychiatry. 2016 Jan 12;6:e710
26756903
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9561-6
10920191
N Engl J Med. 2004 Oct 21;351(17):1707-9
15470193
BMJ. 2016 Jul 14;354:i3942
27417997
N Engl J Med. 2015 Jan 22;372(4):392-4
25607446
Springerplus. 2013 May 24;2(1):236
23750331
Health Aff (Millwood). 2016 Jul 1;35(7):1230-6
27385238
Cannabis Cannabinoid Res. 2016 Jul 01;1(1):154-165
28861491
J Toxicol. 2013;2013:378168
23737769
J Clin Psychopharmacol. 2004 Jun;24(3):305-13
15118485
Lancet Neurol. 2016 Mar;15(3):270-8
26724101
Arch Gen Psychiatry. 2001 Oct;58(10):909-15
11576028
Lancet. 2003 Nov 8;362(9395):1517-26
14615106
J Pharm Sci. 2006 Jun;95(6):1308-17
16637053
Addiction. 2002 Jun;97(6):621-32
12084124
Annu Proc Assoc Adv Automot Med. 2005;49:327-41
16179157
Monaldi Arch Chest Dis. 2005 Jun;63(2):93-100
16128224
Am J Psychiatry. 2004 Nov;161(11):1967-77
15514394
Br J Pharmacol. 2011 Aug;163(7):1344-64
21749363
J AOAC Int. 2015 Nov-Dec;98(6):1503-22
26651562
Clin Psychol Rev. 2017 Feb;51:15-29
27816801
Chem Biodivers. 2007 Aug;4(8):1770-804
17712819
JAMA Intern Med. 2014 Oct;174(10):1668-73
25154332
Ann Intern Med. 2003 Aug 19;139(4):258-66
12965981
Prim Health Care Res Dev. 2013 Apr;14(2):192-9
22784399
JAMA. 2002 Mar 6;287(9):1123-31
11879109
Psychopharmacology (Berl). 1982;76(3):245-50
6285406
Phytomedicine. 2001 Sep;8(5):401-9
11695885
Expert Rev Neurother. 2008 Jul;8(7):1037-48
18590475
Addiction. 2008 Oct;103(10):1671-7
18705690
Mult Scler. 2006 Oct;12(5):639-45
17086911
PLoS One. 2016 Jan 19;11(1):e0147286
26784441
Ther Clin Risk Manag. 2008 Feb;4(1):245-59
18728714
Trials. 2012 Oct 09;13:189
23046749
Addiction. 2009 Nov;104(11):1856-61
19832786
Neuropsychopharmacology. 2010 Aug;35(9):1879-85
20428110
Br J Pharmacol. 2015 Feb;172(3):737-53
25257544
Clin Pharmacol Ther. 2007 Nov;82(5):572-8
17429350
Nat Rev Neurosci. 2016 May;17(5):293-306
27052382
Psychopharmacology (Berl). 2005 Sep;181(2):237-43
15830233
Accid Anal Prev. 2004 Jul;36(4):631-6
15094417
Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):31-9
15159679
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9099-104
18574142
Am J Med. 2007 Sep;120(9 Suppl 1):S18-24; discussion S24
17720356
Hum Psychopharmacol. 2011 Apr;26(3):224-36
21671456
BMJ Open. 2016 Apr 05;6(4):e009986
27048634
J Pharm Pharmacol. 2003 Dec;55(12):1687-94
14738597
Eur Neurol. 2014;71 Suppl 1:4-9
24457846
Addiction. 2010 Aug;105(8):1326-30
20148792
J Pain. 2012 May;13(5):438-49
22483680
Mult Scler. 2004 Aug;10(4):434-41
15327042
Ann Am Thorac Soc. 2013 Jun;10(3):239-47
23802821
Cannabis Cannabinoid Res. 2016 Jan 01;1(1):44-46
28861479
Addict Behav. 2014 Oct;39(10):1430-3
24930049
J Toxicol Sci. 2015 Dec;40(6):797-803
26558460
Expert Opin Drug Saf. 2011 Sep;10(5):675-85
21542664
Med Hypotheses. 2006;66(2):234-46
16209908
Inhal Toxicol. 2009 Nov;21(13):1108-12
19852551
Br J Psychiatry. 2008 Apr;192(4):306-7
18378995
Drug Alcohol Depend. 2003 Jul 20;71(1):37-48
12821204
Ann N Y Acad Sci. 2000;899:274-82
10863546
Chem Res Toxicol. 1998 Oct;11(10):1209-16
9778318
J Pain Symptom Manage. 2010 Feb;39(2):167-79
19896326
Inhal Toxicol. 2008 Jul;20(9):801-4
18645719
Eur J Pharmacol. 2007 Feb 5;556(1-3):75-83
17157290
Transl Psychiatry. 2012 Mar 20;2:e94
22832859
Mult Scler. 2012 Feb;18(2):219-28
21878454
Ann N Y Acad Sci. 1976;282:221-39
798533